Canada Question
Pfizer to offer low-cost meds and vaccines to 45 developing countries

Pfizer to offer low-cost meds and vaccines to 45 developing countries

Pfizer to offer low-cost meds and vaccines to 45 developing countries

Pfizer said Wednesday that it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world’s poorest countries.

The drugmaker announced the program at the World Economic Forum’s annual gathering in Davos, Switzerland, and said it was aimed at improving health equity in 45 lower-income countries. Most of the countries are in Africa, but the list also includes Haiti, Syria, Cambodia and North Korea.

The products, which are widely available in the US and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions. Company spokes Pam Epersonisele said only a small number of the medicines and vaccines are currently available in the 45 countries.

New York-based Pfizer will charge only manufacturing costs and “minimal” distribution expenses, Eisele said. It will comply with any sanctions and all other applicable laws.

The drugmaker also plans to provide help with public education, training for health care providers and drug supply management.

“What we discovered through the pandemic was that supply was not enough to resolve the issues that these countries are having,” Pfizer Chairman and CEO Albert Bourla said Wednesday during a talk at Davos.

Vials with Pfizer/BioNTech’s Comirnaty vaccine are pictured at a production facility in Germany last year. Pfizer’s CEO said billions of doses of the company’s COVID-19 vaccine have been offered for free to low-income countries, mainly through the US government. (Christian Charisius/Reuters)

He noted that billions of doses of the company’s COVID-19 vaccine, Comirnaty, have been offered for free to low-income countries, mainly through the US government, but those doses can’t be used right now.

Earlier this month, the head of the World Health Organization called on Pfizer to make its COVID-19 treatment more widely available in poorer countries.

Comirnaty brought in nearly $37 billion US in sales last year, and analysts expect the company’s COVID-19 treatment Paxlovid to add almost $24 billion US this year, according to the data firm FactSet.

Follow us

Don't be shy, get in touch. We love meeting interesting people and making new friends.

Most popular

Most discussed